Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Pliant Therapeutics, Inc. (PLRX)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 68,801,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Pliant Therapeutics is a clinical stage biopharmaceutical company focused on discovering and developing therapies for the treatment of fibrosis and related diseases. Co.'s focus is on treating fibrosis by inhibiting integrin-mediated activation of TGF-ss. Co.'s main product candidate, PLN-74809, is a dual selective inhibitor of avss6 and avss1 integrins that Co. is developing for the treatment of idiopathic pulmonary fibrosis and primary sclerosing cholangitis. Co.'s second product candidate, PLN-1474, is a selective inhibitor of avss1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis, which Co. has partnered with Novartis Institutes for Biomedical Research, Inc.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 134,221 213,717 457,128
Total Sell Value $0 $1,501,298 $2,420,272 $6,824,069
Total People Sold 0 6 6 6
Total Sell Transactions 0 7 12 26
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 156
  Page 1 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Lefebvre Eric Chief Medical Officer   •       –      –    2025-01-23 4 A $0.00 $0 D/D 45,650 240,224     -
   Cheung Lily Chief Human Resource Officer   •       –      –    2025-01-23 4 A $0.00 $0 D/D 25,875 50,425     -
   Coulie Bernard President and CEO   •       •      –    2025-01-23 4 A $0.00 $0 D/D 162,500 593,017     -
   Cummings Keith Lamont Chief Financial Officer   •       –      –    2025-01-23 4 A $0.00 $0 D/D 56,650 319,258     -
   Ouimette Mike General Counsel & Corp. Secy   •       –      –    2025-01-23 4 A $0.00 $0 D/D 35,000 105,544     -
   Hull Hans Chief Business Officer   •       –      –    2025-01-23 4 A $0.00 $0 D/D 40,150 251,708     -
   Ouimette Mike General Counsel & Corp. Secy   •       –      –    2025-01-22 4 AS $10.99 $112,462 D/D (10,230) 70,544     -
   Lefebvre Eric Chief Medical Officer   •       –      –    2025-01-17 4 AS $11.20 $206,974 D/D (18,478) 194,574     -
   Cummings Keith Lamont Chief Financial Officer   •       –      –    2025-01-17 4 AS $11.20 $225,680 D/D (20,148) 262,608     -
   Ouimette Mike General Counsel & Corp. Secy   •       –      –    2025-01-17 4 AS $11.20 $148,639 D/D (13,270) 80,774     -
   Coulie Bernard President and CEO   •       •      –    2025-01-17 4 AS $11.20 $587,150 D/D (52,419) 430,517     -
   Hull Hans Chief Business Officer   •       –      –    2025-01-17 4 AS $11.20 $178,501 D/D (15,936) 211,558     -
   Cheung Lily Chief Human Resource Officer   •       –      –    2025-01-17 4 AS $11.20 $41,892 D/D (3,740) 24,550     -
   Hull Hans Chief Business Officer   •       –      –    2024-07-10 4 AS $11.56 $114,444 D/D (9,900) 227,494     -
   Cummings Keith Lamont Chief Financial Officer   •       –      –    2024-07-10 4 AS $11.56 $126,131 D/D (10,911) 282,115     -
   Lefebvre Eric Chief Medical Officer   •       –      –    2024-07-10 4 AS $11.56 $142,408 D/D (12,319) 213,052     -
   Coulie Bernard President and CEO   •       •      –    2024-07-10 4 AS $11.56 $447,488 D/D (38,710) 482,936     -
   Ouimette Mike General Counsel & Corp. Secy   •       –      –    2024-07-10 4 AS $11.56 $88,503 D/D (7,656) 94,044     -
   Lefebvre Eric Chief Medical Officer   •       –      –    2024-07-09 4 A $0.00 $0 D/D 24,063 225,371     -
   Hull Hans Chief Business Officer   •       –      –    2024-07-09 4 A $0.00 $0 D/D 19,337 237,394     -
   Coulie Bernard President and CEO   •       •      –    2024-07-09 4 A $0.00 $0 D/D 75,625 521,646     -
   Cummings Keith Lamont Chief Financial Officer   •       –      –    2024-07-09 4 A $0.00 $0 D/D 21,313 293,026     -
   Ouimette Mike General Counsel & Corp. Secy   •       –      –    2024-07-09 4 A $0.00 $0 D/D 14,954 101,700     -
   Cummings Keith Lamont Chief Financial Officer   •       –      –    2024-05-02 4 OE $2.08 $43,680 D/D 21,000 271,713     -
   Cheung Lily Chief Human Resource Officer   •       –      –    2024-01-23 4 A $0.00 $0 D/D 26,000 26,795     -
  156 Records found
  1  2  3  4  5  6  7   
  Page 1 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us